All regulations
Nonrulemaking
FDA
FDA-2026-N-3241
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; KRESLADI (marnetegragene autotemcel)
Documents
1
Comments
0
Key Dates
Comment Period OpensApr 2, 2026
Documents
| Type | Title | Status |
|---|---|---|
Notice |
Keywords
2026-195
CBER
Issuance of Priority Review Voucher
Rare Pediatric Disease Product
KRESLADI marnetegragene autotemcel
OPEN
Data from Regulations.gov